PHASE II TRIAL OF A SURVIVIN VACCINE (SurVaxM) FOR NEWLY DIAGNOSED GLIOBLASTOMA

被引：0
|
作者：
Ahluwalia, Manmeet [1 ]
Reardon, David [2 ]
Abad, Ajay [3 ]
Curry, William [4 ]
Wong, Eric [5 ]
Peereboom, David [1 ]
Belal, Ahmed [3 ]
Qiu, Jingxin [3 ]
Mogensen, Kathleen [3 ]
Schilero, Cathy [1 ]
Casucci, Danielle [3 ]
Mechtler, Laszlo [3 ]
Uhlmann, Erik [3 ]
Ciesielski, Michael [3 ]
Fenstermaker, Robert [3 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02115 USA
[5] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ATIM-41
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
  • [41] A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
    Schuster, James
    Lai, Rose K.
    Recht, Lawrence D.
    Reardon, David A.
    Paleologos, Nina A.
    Groves, Morris D.
    Mrugala, Maciej M.
    Jensen, Randy
    Baehring, Joachim M.
    Sloan, Andrew
    Archer, Gary E.
    Bigner, Darell D.
    Cruickshank, Scott
    Green, Jennifer A.
    Keler, Tibor
    Davis, Thomas A.
    Heimberger, Amy B.
    Sampson, John H.
    NEURO-ONCOLOGY, 2015, 17 (06) : 854 - 861
  • [42] Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma
    Faye, Mame Daro
    Easaw, Jacob
    De Robles, Paula
    Agnihotram, Raman
    Torres-Vasquez, Alexander
    Lamonde, Frederic
    Petrecca, Kevin
    Owen, Scott
    Panet-Raymond, Valerie
    Shenouda, George
    Souhami, Luis
    Azam, Maryam
    Hossain, Bushra
    Alkass, Jad
    Sabri, Siham
    Abdulkarim, Bassam
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
  • [43] PRICOTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Glas, M.
    Scheffler, B.
    Lazaridis, L.
    Herrlinger, U.
    Pierscianek, D.
    Sure, U.
    Proescholdt, M.
    Hau, P.
    Hense, J.
    Kleinschnitz, C.
    Grosu, A.
    Stuschke, M.
    Kebir, S.
    NEURO-ONCOLOGY, 2018, 20 : 243 - 243
  • [44] Glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
    Vaz, M. A.
    del Barco, S.
    Sepulveda, J. M.
    Alonso, M.
    Pineda, E.
    Balana, C.
    Martinez-Garcia, M.
    Girones, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S393 - S393
  • [45] A PHASE 0 'TRIGGER' TRIAL OF NIRAPARIB IN NEWLY-DIAGNOSED GLIOBLASTOMA PATIENTS
    Sanai, Nader
    Margaryan, Tigran
    Molloy, Jennifer
    Knight, William
    Harmon, Jocelyn
    Hong, Amy
    Wanebo, John
    Kennedy, William
    Garcia, Michael
    Barani, Igor
    Yoo, Wonsuk
    Tien, An-Chi
    Tovmasyan, Artak
    Mehta, Shwetal
    NEURO-ONCOLOGY, 2022, 24 : 73 - 73
  • [46] A phase 0/2 trigger trial of niraparib in patients with newly diagnosed glioblastoma
    Mehta, Shwetal
    Sanai, Nader
    Margaryan, Tigran
    Molloy, Jennifer
    Zhang, Hualin
    Knight, William
    Harmon, Jocelyn
    Hong, Amy
    Wanebo, John
    Braun, Kelly
    Kennedy, William R.
    Garcia, Michael A.
    Barani, Igor J.
    Yoo, Wonsuk
    Tien, An-Chi
    Tovmasyan, Artak
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] Phase 2 trial of bavituximab with chemoradiation and adjuvant temozolomide in newly diagnosed glioblastoma
    Ly, Ina
    Richardson, Leland
    Liu, Mofei
    Muzikansky, Alona
    Lou, Kevin
    Reardon, David A.
    Arrillaga-Romany, Isabel
    Forst, Deborah Anne
    Jordan, Justin T.
    Lee, Eudocia Quant
    Dietrich, Jorg
    Nayak, Lakshmi
    Wen, Patrick Y.
    Chukwueke, Ugonma Nnenna
    Giobbie-Hurder, Anita
    Choi, Bryan D.
    Batchelor, Tracy
    Kalpathy-Cramer, Jayashree
    Curry, William T.
    Gerstner, Elizabeth R.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [48] A PHASE 0 'TRIGGER' TRIAL OF PAMIPARIB IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA PATIENTS
    Sanai, Nader
    Chang, Yu-Wei
    Jiang, Jun
    Molloy, Jennifer
    Montgomery, Chelsea
    Harmon, Jocelyn
    Hong, Amy
    Wanebo, John
    Kennedy, William
    Garcia, Michael
    Barani, Igor
    Yoo, Wonsuk
    Tovmasyan, Artak
    Tien, An-Chi
    Li, Jing
    Mehta, Shwetal
    NEURO-ONCOLOGY, 2022, 24 : 82 - 82
  • [49] A phase 0 'trigger' trial of pamiparib in newly diagnosed and recurrent glioblastoma patients
    Sanai, N.
    Mehta, S. N.
    Chang, Y-W.
    Jiang, J.
    Molloy, J.
    Pennington-Krygier, C.
    Harmon, J.
    Hong, A.
    Wanebo, J.
    Kennedy, W.
    Garcia, M.
    Barani, I.
    Yoo, W.
    Tovmasyan, A.
    Tien, A-C.
    Li, J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S670 - S670
  • [50] Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma -: A phase II study
    Wick, W
    Hermisson, M
    Kortmann, RD
    Küker, WM
    Duffner, F
    Dichgans, J
    Bamberg, M
    Weller, M
    JOURNAL OF NEURO-ONCOLOGY, 2002, 59 (02) : 151 - 155
12345